You are here

  • Home
  • Archive
  • Volume 93, Issue 1098
  • A study in high-risk, maximally pretreated patients to determine the potential use of PCSK9 inhibitors at various thresholds of total and LDL cholesterol levels

Article info

Article menu
Download PDFPDF
Original article
A study in high-risk, maximally pretreated patients to determine the potential use of PCSK9 inhibitors at various thresholds of total and LDL cholesterol levels

Authors

  • Carl Groves Department of Clinical Biochemistry, Heart of England Foundation NHS Trust, Sutton Coldfield, UK PubMed articlesGoogle scholar articles
  • Chandrashekar Shetty Department of Clinical Biochemistry, Worcestershire Acute Hospitals NHS Trust, Worcester, Worcestershire, UK PubMed articlesGoogle scholar articles
  • Richard C Strange Institute for Science and Technology in Medicine, Keele University Medical School, Stoke-on-Trent, Staffordshire, UK PubMed articlesGoogle scholar articles
  • Julian Waldron Department of Clinical Biochemistry, University Hospitals of North Midlands, Stoke-on-Trent, Staffordshire, UK PubMed articlesGoogle scholar articles
  • Sudarshan Ramachandran Department of Clinical Biochemistry, Heart of England Foundation NHS Trust, Sutton Coldfield, UK Department of Clinical Biochemistry, University Hospitals of North Midlands, Stoke-on-Trent, Staffordshire, UK Faculty of Health Sciences, Staffordshire University, Stoke-on-Trent, Staffordshire, UK PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Sudarshan Ramachandran, Department of Biochemistry, Good Hope Hospital, Heart of England Foundation NHS Trust, Rectory Road, Sutton Coldfield B75 7RR, UK; sud.ramachandran{at}heartofengland.nhs.uk
View Full Text

Citation

Groves C, Shetty C, Strange RC, et al
A study in high-risk, maximally pretreated patients to determine the potential use of PCSK9 inhibitors at various thresholds of total and LDL cholesterol levels
Postgraduate Medical Journal 2017;93:205-208.

Publication history

  • Received February 28, 2016
  • Revised July 8, 2016
  • Accepted July 25, 2016
  • First published August 16, 2016.
Online issue publication 
March 22, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/